Drug intelligence / Profile preview

Gusongbao Wan

Development stage: Unknown
Lead developer: Beijing Boran Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Gusongbao Wan (骨松宝丸) is an approved traditional Chinese medicine (TCM) herbal pill developed and marketed by **Beijing Boran Pharmaceutical**. Administered orally, it is a multi-herb formulation designed to support bone health and treat bone-related conditions. The name 'Gusongbao' translates to 'bone health treasure,' and in clinical practice, it is primarily indicated for **osteoporosis**. While the specific molecular targets and pharmacological mechanisms of the individual herbal components are not publicly detailed in English-language sources, the product is recognized as an SFDA-certified herbal pharmaceutical in China.

Brand names: Gusongbao Wan
Other names: 骨松宝丸Gusongbao Wan (TCM)

Beyond the preview

Go deeper on Gusongbao Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gusongbao Wan.

Explore the full profile